Show simple item record

dc.contributor.authorKeeble, S
dc.contributor.authorAbel, GA
dc.contributor.authorSaunders, CL
dc.contributor.authorMcPhail, S
dc.contributor.authorWalter, FM
dc.contributor.authorNeal, RD
dc.contributor.authorRubin, GP
dc.contributor.authorLyratzopoulos, G
dc.date.accessioned2019-02-08T09:55:29Z
dc.date.issued2014-02-14
dc.description.abstractCancer awareness public campaigns aim to shorten the interval between symptom onset and presentation to a doctor (the 'patient interval'). Appreciating variation in promptness of presentation can help to better target awareness campaigns. We explored variation in patient intervals recorded in consultations with general practitioners among 10,297 English patients subsequently diagnosed with one of 18 cancers (bladder, brain, breast, colorectal, endometrial, leukaemia, lung, lymphoma, melanoma, multiple myeloma, oesophageal, oro-pharyngeal, ovarian, pancreatic, prostate, renal, stomach, and unknown primary) using data from of the National Audit of Cancer Diagnosis in Primary Care (2009-2010). Proportions of patients with 'prompt'/'non-prompt' presentation (0-14 or 15+ days from symptom onset, respectively) were described and respective odds ratios were calculated by multivariable logistic regression. The overall median recorded patient interval was 10 days (IQR 0-38). Of all patients, 56% presented promptly. Prompt presentation was more frequent among older or housebound patients (p < 0.001). Prompt presentation was most frequent for bladder and renal cancer (74% and 70%, respectively); and least frequent for oro-pharyngeal and oesophageal cancer (34% and 39%, respectively, p <.001). Using lung cancer as reference, the adjusted odds ratios of non-prompt presentation were 2.26 (95% confidence interval 1.57-3.25) and 0.42 (0.34-0.52) for oro-pharyngeal and bladder cancer, respectively. Sensitivity analyses produced similar findings. Routinely recorded patient interval data reveal considerable variation in the promptness of presentation. These findings can help to prioritise public awareness initiatives and research focusing on symptoms of cancers associated with greater risk of non-prompt presentation, such as oro-pharyngeal and oesophageal cancer. What's new? A critical aspect of cancer diagnosis is how promptly patients consult a doctor after they first notice initial symptoms. Here, the authors examine differences in this so-called patient interval in English patients subsequently diagnosed with one of 18 cancers. On average, patients with bladder and renal cancer as well as older and housebound patients consulted a doctor relatively promptly while patients with oro-pharyngeal and oesophageal cancer took the longest until first presenting to a general practitioner. The authors point out that cancer awareness campaigns should encompass symptoms of oro-pharyngeal and oesophageal cancer aiming to shorten the patient interval for these cancers. © 2014 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.description.sponsorshipNHS Public Health Training Schemeen_GB
dc.identifier.citationVol. 135 (5), pp. 1220 - 1228en_GB
dc.identifier.doi10.1002/ijc.28763
dc.identifier.grantnumberPDF-2011-04-047en_GB
dc.identifier.urihttp://hdl.handle.net/10871/35824
dc.language.isoenen_GB
dc.publisherWileyen_GB
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution-Non-Commercial-NoDerivs Licence, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.en_GB
dc.subjectcanceren_GB
dc.subjectpatient intervalen_GB
dc.subjectpromptnessen_GB
dc.subjectpresentationen_GB
dc.subjectdelayen_GB
dc.subjectoro-pharyngealen_GB
dc.titleVariation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: Evidence from a National Audit of Cancer Diagnosis in Primary Careen_GB
dc.typeArticleen_GB
dc.date.available2019-02-08T09:55:29Z
dc.identifier.issn0020-7136
dc.descriptionThis is the final published version. Available from Wiley via the DOI in this record.en_GB
dc.identifier.journalInternational Journal of Canceren_GB
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/en_GB
pubs.euro-pubmed-idMED:24515930
dcterms.dateAccepted2014-01-09
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2014-01-09
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-02-08T09:46:04Z
refterms.versionFCDVoR
refterms.dateFOA2019-02-08T09:55:32Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

This is an open access article under the terms of the Creative Commons Attribution-Non-Commercial-NoDerivs Licence, which permits use and distribution in any medium, provided the original
work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's licence is described as This is an open access article under the terms of the Creative Commons Attribution-Non-Commercial-NoDerivs Licence, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.